Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Ewe

Showing results (141-150 of 150) with videos related to

Pageof 15
Sort By:
You have reached the last page of results.This site can display upto 150 results.
Digestive Diseases and Sciences|March 20, 2003
Replacement of conventional glucocorticoids by oral pH-modified release budesonide in active and inactive Crohn's disease: results of an open, prospective, multicenter trialT Andus, V Gross, I Caesar, et al.
Alimentary Pharmacology & Therapeutics|September 3, 1998
Olsalazine versus mesalazine in the treatment of mild to moderate ulcerative colitisW Kruis, J W Brandes, S Schreiber, et al.
Gut|June 9, 1998
Low dose oral pH modified release budesonide for maintenance of steroid induced remission in Crohn's disease. The Budesonide Study GroupV Gross, T Andus, K W Ecker, et al.
Beitrage Zu Infusionstherapie Und Klinische Ernahrung|January 1, 1986
[Defined formula diet in the treatment of active Crohn disease]H Malchow, H Lorenz-Meyer, H J Steinhardt, et al.
Verhandlungen Der Deutschen Gesellschaft Fur Innere Medizin|January 1, 1975
[Prospective study on hepatitis B antigen-(HBsAg)-positive, healthy blood donors]K H Holtermüller, H G Baumeister, A Arndt-Hanser, et al.
Scandinavian Journal of Gastroenterology|March 1, 1990
Feasibility and effectiveness of a defined-formula diet regimen in treating active Crohn's disease. European Cooperative Crohn's Disease Study IIIH Malchow, H J Steinhardt, H Lorenz-Meyer, et al.
Lancet (London, England)|August 10, 1974
Letter: Prevention of post-transfusion hepatitisA Arndt-Hanser, R Anantharkrishnan, K Ewe, et al.
European Journal of Gastroenterology & Hepatology|September 1, 1996
Oral pH-modified release budesonide versus 6-methylprednisolone in active Crohn's disease. German/Austrian Budesonide Study GroupV Gross, T Andus, I Caesar, et al.
European Journal of Gastroenterology & Hepatology|February 3, 2000
IOIBD questionnaire on the clinical use of azathioprine, 6-mercaptopurine, cyclosporin A and methotrexate in the treatment of inflammatory bowel diseasesS G Meuwissen, K Ewe, M A Gassull, et al.
Zeitschrift Fur Gastroenterologie|July 31, 1999
Anti-TNF antibody in Crohn's disease--status of information, comments and recommendations of an international working groupH Lochs, G Adler, C Beglinger, et al.
Pageof 15

Showing results (141-150 of 150) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 150 results.
Digestive Diseases and Sciences|March 20, 2003
Replacement of conventional glucocorticoids by oral pH-modified release budesonide in active and inactive Crohn's disease: results of an open, prospective, multicenter trialT Andus, V Gross, I Caesar, et al.
Alimentary Pharmacology & Therapeutics|September 3, 1998
Olsalazine versus mesalazine in the treatment of mild to moderate ulcerative colitisW Kruis, J W Brandes, S Schreiber, et al.
Gut|June 9, 1998
Low dose oral pH modified release budesonide for maintenance of steroid induced remission in Crohn's disease. The Budesonide Study GroupV Gross, T Andus, K W Ecker, et al.
Beitrage Zu Infusionstherapie Und Klinische Ernahrung|January 1, 1986
[Defined formula diet in the treatment of active Crohn disease]H Malchow, H Lorenz-Meyer, H J Steinhardt, et al.
Verhandlungen Der Deutschen Gesellschaft Fur Innere Medizin|January 1, 1975
[Prospective study on hepatitis B antigen-(HBsAg)-positive, healthy blood donors]K H Holtermüller, H G Baumeister, A Arndt-Hanser, et al.
Scandinavian Journal of Gastroenterology|March 1, 1990
Feasibility and effectiveness of a defined-formula diet regimen in treating active Crohn's disease. European Cooperative Crohn's Disease Study IIIH Malchow, H J Steinhardt, H Lorenz-Meyer, et al.
Lancet (London, England)|August 10, 1974
Letter: Prevention of post-transfusion hepatitisA Arndt-Hanser, R Anantharkrishnan, K Ewe, et al.
European Journal of Gastroenterology & Hepatology|September 1, 1996
Oral pH-modified release budesonide versus 6-methylprednisolone in active Crohn's disease. German/Austrian Budesonide Study GroupV Gross, T Andus, I Caesar, et al.
European Journal of Gastroenterology & Hepatology|February 3, 2000
IOIBD questionnaire on the clinical use of azathioprine, 6-mercaptopurine, cyclosporin A and methotrexate in the treatment of inflammatory bowel diseasesS G Meuwissen, K Ewe, M A Gassull, et al.
Zeitschrift Fur Gastroenterologie|July 31, 1999
Anti-TNF antibody in Crohn's disease--status of information, comments and recommendations of an international working groupH Lochs, G Adler, C Beglinger, et al.
Pageof 15